
The Ebola virus was first discovered in 1976 near the Ebola River in what is now the DRC. Licensed vaccines such as Merck’s Ervebo have since shown strong protection against the Zaire strain of Ebola. But no approved vaccine or specific antiviral treatment ye…
By Jennifer Rigby, Mariam Sunny and Siddhi Mahatole June 1 (Reuters) - Global health organisation CEPI will give roughly $60 million to Moderna and to two ot...
A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. Researchers at Oxford University are also rapidly advancing vaccine development. These efforts aim to combat the fast-…
BREAKINGThe vaccine, which hasn’t been tested on humans, would be the first capable of treating the deadly Bundibugyo strain of Ebola.
Key market opportunities in the Ebola virus vaccine sector include advancements in mRNA technology, demand for immunization in outbreak-prone regions, and collaboration between pharmaceutical firms, governments, and NGOs. Challenges in distribution logistics …